Duncan Jason reported grant involving 500,000 derivative units of enGene Therapeutics Inc. at $0.00 for $0 on Nov 13, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Legal & Admin Officer
Chief Legal & Admin Officer
Filed Nov 13, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
500,000Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
500,000Direct
Trade date
Nov 13, 2026Grant
Filed
Nov 13, 2026, 4:54 PM ET0-day reporting delay
Accession
0001552781-26-000553Code A · Transaction 400967
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

ENGN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ENGN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago 0%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The stock options vest as to 25% of the total number of shares on the first anniversary of November 13, 2026, and the remainder vesting and becoming exercisable in substantially equal amounts monthly for three years thereafter, subject to the reporting person's continued service.